Graft-versus-host Disease Clinical Trial
Official title:
A Prospective Randomized Study Comparing Rapamune and Tacrolimus vs. Cyclosporine and Methotrexate as Immune Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation, Using HLA-A, -B, -DRĪ²1 Identical Related or Unrelated Donors. A Nordic Multicenter Study.
To evaluate if rapamune + tacrolimus immunosuppressive prophylaxis is better than the established therapy using cyclosporine and methotrexate, a Nordic prospective multicenter randomized study will be performed. Patients will be randomized to treatment with rapamune combined with tacrolimus, or the established therapy using cyclosporine and methotrexate.
Primary endpoint The primary endpoint is grade II-IV acute GVHD in the two groups. GVHD is
diagnosed clinically and graded from 0 to IV. The diagnosis is clinical and biopsies from
skin, liver and gut is used according to the routines at each participating center.
Other study parameters
1. Time to neutrophils >0.5 x 109/L.
2. Time to platelets >20 x 109/L and 50 x 109/L.
3. Platelet level 30 days after transplant.
4. Transfusion requirements of platelets, erythrocytes, granulocyte transfusions during
the first 30 days.
5. Non-engraftment (graft failure/rejection).
6. Grade of acute GVHD.
7. Incidence of chronic graft-versus-host disease graded as limited or extensive and mild,
moderate and severe.
8. Transplant-related mortality.
9. Probability of relapse in patients with haematological malignancies.
10. Survival.
11. Relapse-free survival.
12. Infections by bacteria, virus and fungi. Cytomegalovirus reactivation is also followed
by PCR.
13. Side-effects. Side-effects regarding hematopoiesis, liver test, renal function, cardiac
function, neurology, endocrinology, etc., are taken from the patients' charts. These
parameters are followed regularly after transplantation.
Inclusion criteria Chronic myeloid leukemia (CML) in 1st or 2nd chronic phase, acute myeloid
leukemia (AML) in complete remission, acute lymphoblastic leukemia (ALL) in complete
remission, myelodysplastic syndrome, chronic lymphocytic leukemia, lymphoma, non-malignant
disorders, severe aplastic anemia, hemoglobinopathies and metabolic disorders
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01952184 -
Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.
|
N/A | |
Recruiting |
NCT04808466 -
Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
|
Phase 2 | |
Not yet recruiting |
NCT04845490 -
Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
|
Phase 2 | |
Recruiting |
NCT03291275 -
Survival Outcomes of Uterine Malignancies in Chinese Population
|
N/A | |
Recruiting |
NCT05720858 -
Telerehabilitation in Survival Breast Cancer Patients
|
N/A | |
Completed |
NCT03351920 -
Ventilation's Parameters Applied in Emergency Medicine. A Prospective Observational Study
|
||
Not yet recruiting |
NCT06147180 -
Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
|
||
Recruiting |
NCT04472403 -
Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma
|
||
Recruiting |
NCT03739944 -
Different Surgical Approaches in Patients of Early-stage Cervical Cancer
|
Phase 3 | |
Not yet recruiting |
NCT02960061 -
Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer
|
Phase 3 | |
Recruiting |
NCT03738969 -
Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer
|
||
Completed |
NCT03134807 -
The Very Old Intensive Care Patient: A Multinational Prospective Observation Study
|
||
Completed |
NCT03084809 -
Chemotherapy Combined With CIK Treating Colon Cancer
|
Phase 4 | |
Completed |
NCT03642041 -
Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients
|
||
Recruiting |
NCT04351308 -
Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma
|
Phase 2 | |
Recruiting |
NCT03920033 -
Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy
|
N/A | |
Recruiting |
NCT05540119 -
Swedish Oesophago-Gastric Study
|
||
Completed |
NCT04519450 -
Ultrasound of Accessory Respiratory Muscles
|
||
Active, not recruiting |
NCT01835821 -
Clinical Study of Porcelain-fused and IPS e.Max CAD Crowns
|
N/A | |
Completed |
NCT00565188 -
Application of ATP Infusions in Palliative Home Care
|
Phase 3 |